Johnson & Johnson (JNJ) Restructuring Costs (2010 - 2026)
Johnson & Johnson (JNJ) posted Restructuring Costs of $32.0 million for Q1 2026, down 61.9% sequentially from $84.0 million in Q4 2025, and up 88.24% YoY from $17.0 million in Q1 2025.
Johnson & Johnson (JNJ) Restructuring Costs (2010 - 2026) Analysis & Trends
Johnson & Johnson (JNJ) has 14 years of Restructuring Costs data on file, last reported at $32.0 million in Q1 2026.
- Quarterly Restructuring Costs rose 88.24% year-over-year to $32.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $243.0 million (up 179.31% YoY) and the FY2025 annual result came in at $228.0 million, down 2.56% from the prior year.
- Restructuring Costs eased to $32.0 million in Q1 2026 per JNJ's latest filing, from $84.0 million in the prior quarter.
- The five-year high for Restructuring Costs was $164.0 million in Q1 2024, with the low at -$13.0 million in Q2 2024.
- Average Restructuring Costs over 5 years is $77.0 million, with a median of $65.0 million recorded in 2022.
- Year-over-year, Restructuring Costs sank 108.97% in 2024 and surged 592.31% in 2025.
- Johnson & Johnson's Restructuring Costs stood at $65.0 million in 2022, then dropped by 13.85% to $56.0 million in 2023, then decreased by 25.0% to $42.0 million in 2024, then soared by 100.0% to $84.0 million in 2025, then sank by 61.9% to $32.0 million in 2026.
- Business Quant data shows JNJ's Restructuring Costs at $32.0 million in Q1 2026, $84.0 million in Q4 2025, and $63.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 32.00 Mn |
| Dec 28, 2025 | 84.00 Mn |
| Sep 28, 2025 | 63.00 Mn |
| Jun 29, 2025 | 64.00 Mn |
| Mar 30, 2025 | 17.00 Mn |
| Dec 29, 2024 | 42.00 Mn |
| Sep 29, 2024 | 41.00 Mn |
| Jun 30, 2024 | -13.00 Mn |
| Mar 31, 2024 | 164.00 Mn |
| Dec 31, 2023 | 56.00 Mn |
| Oct 1, 2023 | 158.00 Mn |
| Jul 2, 2023 | 145.00 Mn |
| Apr 2, 2023 | 130.00 Mn |
| Jan 1, 2023 | 106.00 Mn |
| Oct 2, 2022 | 65.00 Mn |
| Jul 3, 2022 | 85.00 Mn |
| Apr 3, 2022 | 70.00 Mn |
| Oct 3, 2021 | 60.00 Mn |
| Jul 4, 2021 | 56.00 Mn |
| Apr 4, 2021 | 53.00 Mn |